Credits: Canva
When the sun is out after a long winter, every one loves it. But not the people of Canary Islands. Tourists there are being warned about the "unusually high risk" of UV rays this week. The Ministry of Health for this holiday destination has urged both, residents and visitors to take extra precautions and preventative measures to limit the impact of sun exposure over their body and skin.
The Ministry observed Aemet, Spain's national weather agency for the forecast which showed higher than normal UV or ultraviolet radiation levels in the region. It is in this backdrop that everyone in the region are requested to be extra careful when they are out in the sun. UV levels are set to reach 7, which is a 'high risk' in La Palma, El Hierro, La Gomera and Gran Canaria. Other regions like Tenerife, Fuerteventura and Lanzarote are expected to reach a level 6, which is also classed as 'high risk'.
As per the World Health Organization (WHO), a UV index is a measure of the level of UV radiation, which ranges from zero upward. The higher the UVI, the greater potential for damage to skin and eye and the less time it takes for harm to occur, notes WHO.
The range 1 to 2 represents a low risk, 2 to 5 is moderate, 6 to 7 is at high risk, 8 to 10 is at very high and anything over 11 is extremely risky for anyone to stay out.
UV radiation levels fluctuate throughout the day, with the highest values occurring during the four-hour period around solar noon. The reported UV Index (UVI) typically reflects this daily peak. Depending on geographic location and the use of daylight saving time, solar noon falls between 12 p.m. and 2 p.m. In some countries, sun protection advisories are issued when UV levels are expected to reach 3 or higher, as exposure at these levels increases the risk of skin damage, making protective measures essential.
While sun bathing is good, being out in the sun when the UVI indicates a high or very high risk, may cause you health concerns. It can lead to sunburn, premature skin aging, incresed risk of skin cancer, eye damage and in severe cases, heat related disease.
It is one of the most common skin injury which happens when there is excess exposure to UV radiation from the sun. This happens when the UV radiation directly damages the DNA skin cells. These damaged cells die and shed, this is why people experience peeling after getting a sunburn.
This is also a common occurrence when your body loses too many fluids or electrolytes. It can also interfere with your normal body functions. You may feel dehydrated, especially when you are out in the sun, but not well hydrated. The most common symptoms are dizziness, fatigue and headache on hot days.
This is an electrolyte disorder in which your body experiences low sodium in blood. The symptoms could lead to nausea, confusion and even weakness. There are extreme cases when one may have seizures, slip into coma or die.
This is one of the most common consequence of being out under the hot sun. Dehydration with prolonged heat exposure can lead to heat exhaustion.
When you are out under the sun and your body's core temperature cross 104°, heatstroke may occur. This is also known as sunstroke. As per the Centers for Disease Control and Prevention (CDC), it causes more than 600 deaths each year in the United States.
Credits: Canva
The first known case of a more severe strain of Mpox has been discovered in the New York City. This is the Mpox clade 1. Clade 1 strain has a higher mortality rate than Clade 2. According to the latest records, the former strain has a mortality rate of 1-10% compared to Clade 2's 1-4%. Moreover, statistics have shown that Clade 1 infects children more than adults. People with Mpox are considered infectious until all their lesions have crusted over, the scabs have fallen off and a new layer of skin has formed underneath, and all the lesions on the eyes and in the body (in the mouth, throat, eyes, vagina and anus) have healed too.
In the US, since November 2024, a total of 11 cases of this severe strain have been detected.
As per the US Centers for Disease Control and Prevention (CDC), these cases were in people who had recently traveled to areas that have Mpox outbreak, including Central and Eastern Africa. Some cases were also seen in people who may not have traveled, but had links to people who did travel to these areas.
The ray of hope here is that the CDC says the risk of clade 1 Mpox to the general public in the US remains low. A two-dose vaccine for Mpox had been made available since 2022 for people at a higher risk.
MPOX is a viral zoonotic disease, meaning it can be transmitted from animals to humans. It is caused by the monkeypox virus, which belongs to the Orthopoxvirus genus, the same family as the variola virus that causes smallpox. The disease was first identified in 1958 when two outbreaks of a pox-like disease occurred in colonies of monkeys kept for research, hence the name "monkeypox." The first human case was recorded in 1970 in the Democratic Republic of Congo, during a period when smallpox was being eradicated.
MPOX symptoms are similar to those of smallpox but are generally milder. After an incubation period of 5 to 21 days, the disease typically begins with fever, headache, muscle aches, and fatigue. Swelling of the lymph nodes, a distinguishing feature of MPOX, occurs before the appearance of the characteristic rash. The rash usually starts on the face and then spreads to other parts of the body, including the palms of the hands and the soles of the feet. Lesions progress through stages—from macules to papules, vesicles, pustules, and finally scabs—before falling off.
While the disease is usually self-limiting, lasting 2 to 4 weeks, severe cases can occur, especially in children, pregnant women, and immunocompromised individuals. Complications can include secondary bacterial infections, respiratory distress, and, in rare cases, death.
Read: Clade 1 Mpox Virus Detected in US Wastewater; How High Is the Risk of Catching The Virus?
MPOX is primarily transmitted through direct contact with the blood, bodily fluids, or skin lesions of infected animals, including rodents and primates. Human-to-human transmission can occur through close contact with respiratory secretions, skin lesions of an infected person, or recently contaminated objects. It can also be transmitted through respiratory droplets in prolonged face-to-face contact.
The recent global outbreaks have highlighted the possibility of transmission through close contact during sexual activities, although MPOX is not considered a sexually transmitted infection in the traditional sense. The virus can enter the body through broken skin, the respiratory tract, or the mucous membranes of the eyes, nose, or mouth.
Given the current global emergency, the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have issued guidelines for preventing MPOX transmission. Key recommendations include:
Credit: Canva
Japan has been granted the world's-first approval for two stem cell–based regenerative therapies, one for Parkinson’s disease and one for severe heart failure.
Stem cells are unspecialized foundational cells with the unique ability to self-renew and differentiate into various specialized cell types, such as muscle, blood or brain cells. They are essential for tissue repair, regeneration, and development, acting as an internal repair system.
Stem cell therapy, or regenerative medicine, uses stem cells or their derivatives to repair, replace, or regenerate diseased, dysfunctional, or injured tissue. It involves guiding stem cells to become specialized cells (heart muscle, nerve, or blood cells) to treat conditions like blood cancers, orthopaedic injuries, and neurodegenerative diseases.
Based on the Japanese approval, the Parkinson’s stem cell therapy treatment uses induced pluripotent stem cells (iPSCs) that are converted into dopamine-producing neurons and transplanted into the brain to replace cells lost during the disease.
Moreover, the heart failure therapy involves placing sheets of stem cell–derived heart muscle cells onto the heart, which may help restore cardiac function by promoting tissue repair and new blood vessel growth.
Both therapies received conditional approval, meaning they can be used clinically while researchers continue to collect additional safety and effectiveness data from patients.
Parkinson's disease is a progressive, neurodegenerative movement disorder caused by the loss of dopamine-producing brain cells, primarily affecting people over 60. Apart from motor loss, the disease also causes cognitive decline, depression, anxiety and swallowing problems.
The first symptom may be a barely noticeable tremor in just one hand or sometimes a foot or the jaw. Over time, swinging your arms may become difficult and your speech may become soft or slurred. The disorder also causes stiffness, slowing of movement and trouble with balance that raises the risk of falls.
While Parkinson’s disease cannot be entirely prevented, experts suggest several lifestyle modifications that may reduce the risk. Dr Himanshu Champaneri, Senior Consultant in the Department of Neurosciences and Neurosurgery at Marengo Asia Hospitals in Gurugram told India Today that physical activity could aid in maintaining brain health. He recommends engaging in at least 150 minutes of moderate-to-intense exercise per week, including walking, running, swimming, and dancing.
Meanwhile, other experts have suggested that certain types of Parkinson's disease such as vascular Parkinsonism, are linked to the hardening of brain blood vessels. To mitigate this risk, she advises regular exercise, a low-fat diet, and monitoring blood pressure, sugar, and cholesterol levels. Additionally, industrial pollution is associated with an increased incidence of Parkinson's.
She suggests spending time in natural environments away from industrial pollutants to help lower the risk.
Credit: Canva
Menstruation is not a disability, and therefore, there is no need for mandatory period leaves, said experts, a day after the Supreme Court of India quashed the petition seeking a menstrual leave policy.
The top court expressed concerns that a law making paid leave during menstrual pain compulsory could harm the careers of young women and deprive them of equal opportunities.
While such a policy may look appealing from a “rights perspective,” the court noted it could have “long-term impacts.”
According to the 2025 Periodic Labor Force Survey (PLFS) data released by the Ministry of Statistics and Program Implementation (MoSPI), women’s labor force participation (LFPR) showed significant growth, reaching 35.3 percent in December 2025, driven largely by a consistent rise in rural areas, which peaked at 40.1 percent.
The female worker population ratio (WPR) also increased, reaching a yearly high in December, highlighting greater engagement in the workforce.
However, India’s female participation remains notably lower than the global average of nearly 49 percent and the OECD average of 67 percent, indicating a persistent, though shrinking, gender gap.
In this context, the court observed that a mandatory period leave policy could create the impression that women “still have some natural issues” and “are not at par with male persons.”
“Will an employer be happy if an employee takes leave every month? You risk creating a situation where employers may be reluctant to hire women,” the bench said.
HealthandMe spoke to several experts who agreed with the Supreme Court’s view, noting that while period pain and related concerns are real, they do not warrant paid leave for all women employees.
Periods affect women worldwide. For some, it comes with severe back pain, headaches, cramps, fatigue, and other symptoms. For others, the days pass with little discomfort.
“I feel mandatory menstrual leave for all female employees is unnecessary. While menstrual issues are real, not everyone suffers from them. Young women experience debilitating pain in about 1 in 10 cases, while women in their 40s may experience heavier bleeding, perhaps debilitating in 1 out of 7 individuals,” Dr. Ruma Satwik, Senior Consultant at Sir Ganga Ram Hospital, New Delhi, told HealthandMe.
Dr. Sabine Kapasi, a public health expert and UN advisor, emphasized that menstrual health deserves significant policy attention.
“But a universal requirement for leave may not be sufficient and is not necessarily the best approach,” she added.
Women have long faced societal and workplace stereotypes, with gender bias evident in wages, hierarchies, and opportunities. A LinkedIn report shows that gender disparity is more pronounced in leadership roles: in 2025, women held only 18 percent of top positions in India, far lower than their overall workforce representation.
“A policy must avoid inadvertently perpetuating gender bias in employment or career advancement,” Kapasi told HealthandMe.
During the Supreme Court hearing, Chief Justice Surya Kant said that with the mandatory menstrual leave law, employers might hesitate to hire women.
“We are creating ‘All Women Teams’ and ‘All Women Service Centers.’ How will they function if such a leave policy is approved? Menstruation is not a disability. It is a biological fact that women have managed over generations,” Indira Murthy, Retired Joint Secretary, Government of India, Advocate, High Court and Supreme Court, and Arbitrator, told HealthandMe.
Experts acknowledged the genuine challenges women face during menstruation and suggested alternative measures, including work-from-home arrangements.
Murthy noted that the Supreme Court emphasized voluntary employer initiatives, while also stating that proper institutional arrangements should ensure hygiene and safety for women and children.
“For some women, periods are very uncomfortable. They may be unable to work during these days. Companies can provide flexibility and allow period leaves,” said Dr. Alpna Kansal, President of IMA Ghaziabad.
Kapasi recommended a more sustained approach in workplaces, urging employers to recognize that conditions like endometriosis or severe dysmenorrhea can significantly impact well-being and productivity.
Flexible, stigma-free policies can help women while maintaining workplace fairness.
“Menstrual health awareness, workplace flexibility, access to care, and supportive leave policies integrated into broader occupational health frameworks should be priorities. Women’s health can be safeguarded with a balanced strategy without causing structural disadvantages at work,” Kapasi added.
Dr. Satwik noted that most cases of pain or heavy bleeding can be managed with medication.
“Only in rare cases would symptoms be refractory to treatment, requiring injections or surgical intervention. Those experiencing debilitating symptoms should be granted leave as part of standard sick leave,” she said.
Murthy emphasized that the Supreme Court did not propose a blanket ban.
“No one-size-fits-all policy works. Policy-making should benefit even the last person in the queue. Work-from-home arrangements are a sustainable solution to this issue,” she said.
© 2024 Bennett, Coleman & Company Limited